Top Markets
#1 0G 0G +41.62%
#2 Useless Coin Useless Coin +37.69%
#3 Merlin's Seal BTC Merlin's Seal BTC +37.35%
#4 SAFEcoin SAFEcoin +29.70%
#5 Arbitrum Arbitrum +28.39%
#6 StonkBroker StonkBroker +27.25%
#7 Pons Pons +22.09%
#8 Notcoin Notcoin +20.52%
#9 Zora Zora +18.90%
#10 Full Moon Full Moon +18.20%
Coin of the day
0G 0G
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Relmada Therapeutics, Inc. Relmada Therapeutics, Inc.

Relmada Therapeutics, Inc.

RLMD
Pozycja w akcjach #13829
Relmada Therapeutics, Inc. operates as a clinical-stage biotechnology company... Relmada Therapeutics, Inc. operates as a clinical-stage biotechnology company in the United States. The company focuses on the development of NDV-01, a controlled-release intravesical formulation of gemcitabine and docetaxel, which is in Phase 2 clinical trial for patients with aggressive forms of non-muscle invasive bladder cancer; and Sepranolone, a neurosteroid epimer of allopregnanolone, which is Phase 2b-ready for the potential treatment of prader-willi syndrome, tourette syndrome, excessive tremor, and other diseases related to excessive GABAergic activity. The company has an agreement with Asarina Pharma AB and Trigone. Relmada Therapeutics, Inc. was founded in 2004 and is headquartered in Coral Gables, Florida.
Cena akcji
$4.36
Kapitalizacja rynkowa
$457.32M
Zmiana (1 dzień)
0.69%
Zmiana (1 rok)
289.29%
Kraj
US
Handel Relmada Therapeutics, Inc. (RLMD)

Kategoria

Healthcare
EPS dla Relmada Therapeutics, Inc. (RLMD)
EPS na dzień 2026 TTM: 0
Według najnowszych raportów finansowych i ceny akcji firmy Relmada Therapeutics, Inc., obecny EPS (TTM) wynosi 0. Na koniec roku 2026 firma miała EPS w wysokości 0, równa się do EPS z roku 2026, który wynosił 0.
Historia EPS dla Relmada Therapeutics, Inc. od 2026 do 2026
EPS na koniec każdego roku
Rok EPS Zmień
Za mało danych dla podanych dat.
EPS dla podobnych firm lub konkurentów
Firma EPS Różnica w EPS Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $-5.29 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $-7.98 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH